Alvaro Alencar, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Zanubrutinib and Tafasitamab in Mantle Cell Lymphoma (NCT06029309) | Alvaro Alencar, MD | 2024-05-03 |
Track Alvaro Alencar, MD automatically
Every clearance here is in the API, with alerts when new ones post.